2 results
Approved WMOCompleted
To evaluate the effects of COS with tamoxifen or letrozole compared to standard COS, on oocytes retrieved.
Approved WMORecruiting
The primary objective of the study is to determine the efficacy of AP26113, as evidenced by objective response rate, in patients with ALK positive locally advanced or metastatic NSCLC whose disease has progressed on therapy with crizotinib.